Conversion from calcineurin inhibitors to belatacept-based immunosuppressive therapy skews terminal proliferation of non-classical monocytes and lowers lymphocyte counts

Obbo W Bredewold(Leiden University Medical Center), Hetty C. de Boer(Leiden University Medical Center), Joris I. Rotmans(Leiden University Medical Center), Johan W. de Fijter(Antwerp University Hospital), Annemarie M. van Oeveren‐Rietdijk(Leiden University Medical Center), Anton Jan van Zonneveld(Leiden University Medical Center), Cees van Kooten(Leiden University Medical Center), Barend W. Florijn(Leiden University Medical Center)
Transplant Immunology
January 8, 2024
Cited by 2


Related Papers